title: Characterization of a disease-causing Glu119-Lys mutation in the low-density lipoprotein receptor gene in two Danish families with heterozygous familial hypercholesterolemia.
abstract: Mutations in the gene for the low-density lipoprotein receptor (LDL receptor) cause the autosomal dominant inherited disease familial hypercholesterolemia (FH). In 15 Danish patients with heterozygous FH we have screened exon 4 of the LDL receptor gene for point mutations and small rearrangements employing genomic DNA amplification and bidirectional solid-phase sequencing. Two subjects were found to be heterozygous for a guanine to adenine base substitution at nucleotide position 418 of the LDL receptor cDNA. This point mutation results in an amino acid change from glutamic acid to lysine at amino acid residue 119 in the third repeat of the cysteine-rich ligand binding domain of the mature LDL receptor. Disruption of LDL receptor function by the Glu119-Lys mutation was confirmed by site-directed mutagenesis and expression in COS-7 cells. By Western blotting the mutation was found to affect the processing of the LDL receptor protein. Using flow cytometric analysis of the transfected cells a decreased binding and internalization of LDL by the mutant receptor was documented. By means of a mutation-specific PCR-based assay the Glu119-Lys mutation was not detected in another 85 apparently unrelated Danish heterozygous FH patients. We identified six persons in the index families with the Glu119-Lys mutation cosegregating with the clinical syndrome of FH in these families. Furthermore, haplotype analysis revealed that the haplotype [SfaNI+, StuI+, AvaII-, (dTA)7] of the mutation carrying allele was the same in the two apparently unrelated patients. This indicates that the mutation has been inherited from a common ancestor.
authors.affiliation: Center for Medical Molecular Biology, Aarhus University Hospital, Skejby Sygehus, Denmark.
authors.forename: H K
authors.initials: HK
authors.lastname: Jensen
authors.forename: T G
authors.initials: TG
authors.lastname: Jensen
authors.forename: L G
authors.initials: LG
authors.lastname: Jensen
authors.forename: P S
authors.initials: PS
authors.lastname: Hansen
authors.forename: M
authors.initials: M
authors.lastname: Kjeldsen
authors.forename: B S
authors.initials: BS
authors.lastname: Andresen
authors.forename: V
authors.initials: V
authors.lastname: Nielsen
authors.forename: H
authors.initials: H
authors.lastname: Meinertz
authors.forename: A B
authors.initials: AB
authors.lastname: Hansen
authors.forename: L
authors.initials: L
authors.lastname: Bolund
mesh_terms: D000328:Adult; D001483:Base Sequence; D005260:Female; D018698:Glutamic Acid / Q000235:genetics; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000235:genetics*; D008239:Lysine / Q000235:genetics; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010375:Pedigree; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D011973:Receptors, LDL / Q000235:genetics*
chemical_list: D011973:Receptors, LDL; D018698:Glutamic Acid; D008239:Lysine